Skip to main content

Table 1 Differential expression of miRNAs following rituximab therapy

From: Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)

Upregulated miRNAs

Downregulated miRNAs

miRNA treated vs untreated

Fold change

p value

miRNA treated vs untreated

Fold change

p value

hsa-miR-16

1.99

0.00001

hsa-miR-125b (#^)

0.17

0.00001

hsa-miR-15a

2.65

0.00001

hsa-miR-760 (#^)

0.08

0.00005

hsa-miR-124

6.42

0.00012

hsa-miR-135a (#^)

0.18

0.00058

hsa-miR-26b

1.91

0.00044

hsa-miR-134 (#^)

0.1

0.00183

hsa-miR-7

3.8

0.00085

hsa-miR-138 (#^)

0.18

0.00515

hsa-miR-15b

1.79

0.00206

hsa-miR-423-3p (#)

0.4

0.00734

hsa-miR-451

1.85

0.00233

hsa-miR-100 (#)

0.31

0.00818

hsa-miR-454

2.09

0.00458

hsa-miR-125a

0.24

0.00925

hsa-miR-17

1.66

0.00735

hsa-miR-135b(#^)

0.18

0.01455

hsa-miR-144

2.13

0.01293

hsa-miR-203 (#)

0.2

0.01629

hsa-miR-1180

3.53

0.01837

hsa-miR-660 (#)

0.31

0.04582

hsa-miR-106a

1.71

0.01897

hsa-miR-30d

0.34

0.000002

hsa-miR-184

3.41

0.03243

hsa-miR-200c

0.09

0.00003

hsa-miR-374b

1.62

0.03371

hsa-miR-30a

0.18

0.00003

   

hsa-miR-99a

0.1

0.00009

   

hsa-miR-29a

0.25

0.00034

   

hsa-miR-200b

0.1

0.00043

   

hsa-miR-24

0.47

0.00076

   

hsa-miR-30e

0.33

0.001

   

hsa-miR-27b

0.38

0.00199

   

hsa-let-7c

0.44

0.00711

   

hsa-miR-375

0.14

0.00836

   

hsa-miR-152

0.23

0.01717

   

hsa-miR-148b

0.43

0.01862

   

hsa-miR-361-5p

0.23

0.01937

   

hsa-miR-221

0.46

0.02188

   

hsa-miR-200a

0.21

0.02416

   

hsa-miR-328

0.4

0.02717

   

hsa-miR-92a

0.71

0.02719

   

hsa-miR-27a

0.48

0.0307

   

hsa-miR-181a

0.49

0.04338

   

hsa-miR-143

0.38

0.04993

  1. miRNAs with increased expression in NMO patients that were normalized following rituximab therapy are indicated by (#); brain-specific/enriched miRNAs are marked with (^)